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This study aims to evaluate the efficacy of repeated external ± internal EC
in such patients. In case of persistent AF after a first external EC, a repeated
external EC was performed. After the inefficiency of 2 external EC, internal
cardioversion was perfomed.
Methods: Patients with persistent AF, after inefficient external EC and oral
pretreatment with amiodarone were included. After a mean of 3 months,
repeated external ± internal EC was proposed in order to recover sinus rhythm
(SR). These patients were compared with a control group, sex and age
matched, also treated with amiodarone but in whom the external EC was suc-
cessful at the first attempt.
The 2 groups were analyzed in a case-control study. We analyzed the rate
of successful external EC after the 2 procedures in the AF group. The recur-
rence rate of AF was analyzed after one year in both groups. 
Results: Twenty patients got unsuccessful external EC (mean age=64.1 years).
There were 40 patients in the control group (mean age=67.1 years). External EC
was repeated after a mean of 3.5±5.4 months. No patient needed internal EC.
After one year, there was no difference in the recurrence rate of AF in both groups
(35% vs. 27%; p=0.244, in studied and control groups, respectively).
Conclusion: Repeated external EC allows SR recovery in all the patients
with AF under long term oral amiodarone, after a first unsuccessful external
EC. The AF recurrence rate after one year was similar to patients in whom the
first attempt was successful at once. 
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Circadian behavior of RR ventricular tachycardia cycle length stabi-
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Aim: of the study was to evaluate the possible existence of a nightmare
modulation of VTCL stability in ICD recipients.
Method: We evaluated 45 ICD pts with 104VT episodes occurred both at
day (80) and night (24) time in a FU period of 5±3years. As index of VTCL
stability we considered the coefficient of variance (CVRR=SD/Mean RRX100)
of the last 5-10 consecutive stored normal RR intervals prior to the VT.
Results: During day-night, the VTCL was 340±29ms and 352±45ms
(p=NS) and the CVRR was 2,83±0,52 and 3,36±0,68(p=0.017).
Conclusions: The VTCL is less stable during night compared to the day
time, in pts with DCM. A possible explanation is that, the sympathovagal
nightmare alteration modifies the electrophysiological properties of the
arrhythmogenic substrate. The clinical significance of this study is towards
programming the ICD parameters. 
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Introduction: Very narrow QRS has been described whose prevalence and
prognosis relevance in the normal population is unknown. 
Methods: 546 healthy men between 50 and 60 yo (group 1) and 373 similar
patients with coronary artery disease (368 men, EF < 50% in 40%) (group 2)
underwent signal averaged ECG allowing precise measurement of QRS dura-
tion. All cause mortality was determined after 17±3 years follow-up.
Results: Mean QRS duration was 97±13ms for group 1 and 103±16ms for
group 2. 85 group 1 subjects (16%) had QRS < 85ms and 23 (4%) had QRS
>120ms. 44 group 2 patients (12%) had QRS < 85ms and 44 (12%) had QRS
>120ms. QRS were larger in case of lower EF, lack of previous angioplasty
and multivessel disease. 
All cause mortality in group 1 was 10,4% (57/546): 6/85 in case of QRS
<85ms (7%) and 2/23 (9%) in case of QRS > 120ms (p=ns compared to
normal QRS duration). HR for all-cause mortality in case of QRS < 85ms was
0,75 (95% CI 0.32-1.76, p = 0,52) and 0,86 (95% CI 0.21-3.53, p = 0,84) for
QRS >120ms.
All cause mortality in group 2 was 29% (109/373): 7/44 in case of QRS
<85ms (16%) and 22/44 (50%) in case of QRS > 120ms (p=0.002 when com-
pared to normal QRS duration). Adjusted HR for all-cause mortality in case
of QRS < 85ms was 0,65 (95% CI 0.29-1.45, p = 0,29) and 1.73 (95% CI
1.02-2.94, p = 0,05) for QRS > 120ms. 
Late potentials (LP) were present in SA-ECG in 116 group 1 subjects
(21%). LP were present in 100 group 2 patients (27%) and were significantly
related to multivessel disease, altered EF, lack of revascularization or of
angioplasty. LP were more frequently observed in case of QRS > 120ms in
both groups. LP were nor related to all-cause mortality in both groups.
Conclusion: QRS “narrower than normal” (< 85ms) can be observed in a
significant porpotion of healthy males between 50 and 60 years old and in
similar patients with ischemic heart disease. In opposition to QRS > 120 msec
which are independantly related to a higher all-cause mortality in coronary
artery disease patients, QRS <85ms were not linked to prognosis in any group.
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Background: Following the exponential growth of cardiac device implanta-
tion, there is an increase of lead extraction indications. In the meantime, the tools,
the indications, and the outcomes of those procedures continue to progress.
Objectives: The purpose of this study was to examine contemporary indi-
cations, outcomes, and complications of transvenousleadextraction in a large
series of patients at a high-volume lead extraction center.
Methods: We performed a retrospective cohort study of consecutive
patients undergoing leadextraction at a single, high-volume center.Our extrac-
tion strategy consists in manual traction, locking stylet traction, laser use fol-
lowed by inferior approach in case of failure.
Patient and lead characteristics and the indications, outcomes, and need for
laser assistance were analyzed
Results: From January 2002 to December 2013, a total of 751 chronic
endovascular leads were removed from 391patients.The mean age was years
68 (range 13- 98). Seventy-five percent of patients were males. Median
implantation duration was 5,5 years. Indications for extraction were systemic
infection (33,3%), pocket infection (25,1%), mechanical lead failure (32,7%),
and upgrade of device system (6,1%)due to thrombosis of veinous access.
Extraction was successful in 97,7% of patients with complete removal.
Laser assistance for extraction wasrecquired in 259 patients (66,2%),
completed with an inferior approach in 38 patients(9,7%). Complications were
death in 2 patients (0,5%),bleeding in 21 patients (5,4%), pericardial tam-
ponade in 8 patients (2%).
In univariate analysis, laser-assisted lead extraction was required more fre-
quently for leads that were implanted more 36 months than others (p<0,001),
as well as for passive leads compared to active leads (p=0,04).
Conclusion: Lead extraction can be safely and succefully performed in the
majority of patients, with limited life-threatening complications.
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Introduction: More and more frequently, silent atrial fibrillation (AF)
events are detected in intracardiac electronic device (ICED) memory (“infra-
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clinical AF” or “had atrial high rate events AHRE”). In MOST trial, AHRE
were seen in almost 50% of patients treated for sinus node dysfunctionand
were associated with an increased risk of stroke (1.69% per year if CHADS
score>2) in ASSERT study. Nevertheless currently there are no antithrombotic
recommendations for these patients. We tried to describe the different thera-
peutic alternatives in usual practice.
Materials and methods: We started a prospective registry of patients with
silent AF detected in DDD or CRT PMK/ICD of all constructors. Inclusion
criteria were: age > 18 y, AHRE diagnosed by device algorithms and > 6 min-
utes duration, confirmation by atrial endocavitary electrogram. We excluded
patients with a previous history of “clinical AF”or valvular AF. The anti-
thrombotic strategy was decided by the referent physician.
Results: From November 2013 to May 2014, 43 patients were included.
The median age was 77 years old. 26 patients (60%) had a DDD PMK (10 for
sinus node dysfunction (23%), 15 for AV block (35%), 1 for obstructive
CMP), 10 patients (23%) a DDD ICD (6 (14%) for primary prevention and 4
(9%) for secondary prevention) and 7 patients a CRT-D (16%). The median
CHADS2 score was 2, the median CHADS2VASCscore was 4 (mean respec-
tively 2.36 and 3.56): 5 patients had a history of embolic event (11%). Only
28 patients (65%) were on anticoagulation therapy: 15 (35%) antivitamin K
and 13 (30%) new oral anticoagulants. 10 patients (23%) received aspirin and
5 patients the association aspirin/clopidogrel (11%). 2 patients did not receive
any antithrombotic treatment. There were no difference in CHADS and
CHADSVASC scores between patients treated or not with anticoagulants
(respectively p=0.21 and p =0.57)
Conclusion: Most of patients in this study received an anticoagulation
therapy as a stroke prevention strategy.
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Introduction: Preserved intrinsic conduction in paced sinus node disease
(SND) patients seems to be associated with a better outcome when compared with
apical right ventricular (RV) DDD pacing.The prospective, multicenter, random-
ized OPTIMIST study was designed to compare RV lead positioning in the
septum to preserved intrinsic conduction in chronically paced SND patients.
Methods: SND patients with a class I indication were implanted with a
DDD pacemaker (St. Jude medical), the RV lead being located in the mid-
septum. The algorithm VIP™ (Ventricular Intrinsic Preference) was pro-
grammed « on » in all patients at hospital discharge. After a 6 weeks observa-
tional period, patients with a ventricular pacing percentage inferior to 10%
were randomized in 2 parallel groups: VIP « on » (preserved natural conduc-
tion – group 1) or « off » with AV delay optimization (RV pacing – group 2).
Patients were followed every 6 months with echocardiography through
18 months. The primary endpoint was the left ventricular end-systolic diam-
eter (LVESD) (Corelab analysis), with a non inferiority hypothesis.
Results: 216 patients mean age 76.07±9.45 were included and 167 ran-
domized. The baseline characteristics were comparable in group 1 and 2
including left ventricular ejection fraction, LVEF (62.4±12.6 vs 64.4±8.7%),
LVESD (32.7±8.5 vs 32.5±9.3mm) and 6 weeks RV pacing percentage
(1.81±1.92 vs 2.15±2.07%). At the end of FU, as expected the percentage of
RV pacing was significantly higher in group 2 (78.9±31.6 vs 7.9±17.4%). The
LVEF was 62.3±10.1% in group 1 and 60.9±10.9% in group 2 (NS) and the
LVESD was 31.9±7.23mm in group 1 and 31.26±7.21mm in group 2 (NS).
The non-inferiority hypothesis was validated (p=2.572e-06 for a delta =
4.785). AF burden was not different between the 2 groups.
Conclusion: When implanting the RV lead in the midseptum, DDD pacing
with high percentage of RV capture was not associated with LV echocardio-
graphic deterioration as compared to preserved intrinsic conduction pacing mode. 
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Background: Resting heart rate (RHR) is known as a cardiovascular risk
factor (RF), correlated with hypertension, cardiac failure and coronary artery
disease. The aim of this study was to assess the risk of all-cause mortality in
a general population in a prediction algorithm including RHR as an indepen-
dent parameter.
Methods: Our study population consisted in patients, both women and
men, who had consulted from 1995 to 2011 to the Department of Preventive
Cardiology (DPC) in a Southwestern French University Hospital. We
excluded patients whose age was less than 30 years old and all patients with
established history of ischemic heart disease. An algorithm for prediction of
risk of mortality in primary prevention was built using Kaplan-Meier statistic
and a Cox proportional hazards model.
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